对托皮拉-普托夫斯卡等人《肺动脉高压的超声心动图：综合评估与技术考量》的评论。2021年，，3229。
Comment on Topyła-Putowska et al. Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations. 2021, , 3229.
作者信息
Manzi Giovanna, Vizza Carmine Dario, Badagliacca Roberto
机构信息
Department of Clinical, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Rome, Italy.
出版信息
J Clin Med. 2022 Jun 10;11(12):3337. doi: 10.3390/jcm11123337.
Abstract
A comprehensive PAH echocardiographic examination of patients with pulmonary arterial hypertension (PAH) should include a set of parameters resembling the pathophysiological changes occurring in the course of the disease. This approach could help clinicians build a complete picture of the patient, test the effects of targeted therapies and identify patients who need a more aggressive therapeutic approach to achieve a low risk-status.
摘要
对肺动脉高压（PAH）患者进行全面的PAH超声心动图检查应包括一组类似于疾病过程中发生的病理生理变化的参数。这种方法可以帮助临床医生全面了解患者情况，测试靶向治疗的效果，并识别那些需要更积极治疗方法以实现低风险状态的患者。
相似文献
1
Comment on Topyła-Putowska et al. Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations. 2021, , 3229.
J Clin Med. 2022 Jun 10;11(12):3337. doi: 10.3390/jcm11123337.
2
Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations.
J Clin Med. 2021 Jul 22;10(15):3229. doi: 10.3390/jcm10153229.
3
Right ventricle performances with echocardiography and Tc myocardial perfusion imaging in pulmonary arterial hypertension patients.
Exp Biol Med (Maywood). 2018 May;243(9):754-761. doi: 10.1177/1535370218775321.
4
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC.
5
Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?
J Clin Med. 2021 Jun 26;10(13):2826. doi: 10.3390/jcm10132826.
6
[Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension].
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Dec 24;46(12):965-971. doi: 10.3760/cma.j.issn.0253-3758.2018.12.007.
7
Changes in heart morphometric parameters over the course of a monocrotaline-induced pulmonary arterial hypertension rat model.
J Transl Med. 2020 Jun 30;18(1):262. doi: 10.1186/s12967-020-02440-7.
8
New Echocardiographic Tehniques in Pulmonary Arterial Hypertension vs. Right Heart Catheterization - A Pilot Study.
Maedica (Bucur). 2013 Jun;8(2):116-23.
9
The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension.
Int J Cardiol. 2020 Feb 15;301:183-189. doi: 10.1016/j.ijcard.2019.10.043. Epub 2019 Nov 13.
10
Power of resting echocardiographic measurements to classify pulmonary hypertension patients according to European society of cardiology exercise testing risk stratification cut-offs.
Int J Cardiol. 2018 Apr 15;257:291-297. doi: 10.1016/j.ijcard.2018.01.042. Epub 2018 Jan 31.
引用本文的文献
1
Pulmonary Hypertension: Current Diagnosis, Approach and Treatment at the Dawn of the New European Guidelines.
J Clin Med. 2022 Sep 30;11(19):5804. doi: 10.3390/jcm11195804.
本文引用的文献
1
Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations.
J Clin Med. 2021 Jul 22;10(15):3229. doi: 10.3390/jcm10153229.
2
Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?
J Clin Med. 2021 Jun 26;10(13):2826. doi: 10.3390/jcm10132826.
3
The Growing Role of Echocardiography in Pulmonary Arterial Hypertension Risk Stratification: The Missing Piece.
J Clin Med. 2021 Feb 6;10(4):619. doi: 10.3390/jcm10040619.
4
Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension.
JACC Cardiovasc Imaging. 2021 Jan;14(1):162-172. doi: 10.1016/j.jcmg.2020.08.017. Epub 2020 Oct 28.
5
Usefulness of Adding Echocardiography of the Right Heart to Risk-Assessment Scores in Prostanoid-Treated Pulmonary Arterial Hypertension.
JACC Cardiovasc Imaging. 2020 Sep;13(9):2054-2056. doi: 10.1016/j.jcmg.2020.04.005. Epub 2020 Jun 17.
6
The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension.
Int J Cardiol. 2020 Feb 15;301:183-189. doi: 10.1016/j.ijcard.2019.10.043. Epub 2019 Nov 13.
7
The Right Heart-Pulmonary Circulation Unit: Physiopathology.
Heart Fail Clin. 2018 Jul;14(3):237-245. doi: 10.1016/j.hfc.2018.02.001.
8
Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension.
Int J Cardiol. 2018 Sep 1;266:229-235. doi: 10.1016/j.ijcard.2018.01.053.
9
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension.
J Heart Lung Transplant. 2017 Oct 2. doi: 10.1016/j.healun.2017.09.026.
10
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension.
J Heart Lung Transplant. 2018 Mar;37(3):365-375. doi: 10.1016/j.healun.2017.08.009. Epub 2017 Aug 26.
Zotero 插件